LCTX Lineage Cell Therapeutics, Inc.

AMEX
$0.84

Lineage Cell Therapeutics, Inc. (LCTX) Earnings News

Earnings press releases, previews and reviews for Lineage Cell Therapeutics, Inc. (LCTX), newest first. Our most recent is review: Lineage Cell Therapeutics Misses as Revenue Slides; HUNT1 Deal Trades a Quarter of Cash Runway for a Third Clinical Asset.